Vanderbilt Center for Neuroscience Drug Discovery Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Vanderbilt Center for Neuroscience Drug Discovery's estimated annual revenue is currently $16.5M per year.(i)
  • Vanderbilt Center for Neuroscience Drug Discovery's estimated revenue per employee is $112,200

Employee Data

  • Vanderbilt Center for Neuroscience Drug Discovery has 147 Employees.(i)
  • Vanderbilt Center for Neuroscience Drug Discovery grew their employee count by 14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$23M205N/AN/AN/A
#2
$2.1M29N/AN/AN/A
#3
$1.8M254%N/AN/A
#4
$22.9M20496%N/AN/A
#5
$796.3M557611%N/AN/A
#6
$6M65N/AN/AN/A
#7
$2.1M29-28%N/AN/A
#8
$5.4M590%N/AN/A
#9
$20.2M18015%N/AN/A
#10
$6.6M7213%N/AN/A
Add Company

The Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) extends traditional academic pursuits in basic science to take the most exciting advances in our understanding of human disease and drug targets to a point where these breakthroughs can directly impact patient care. The most innovative and potentially high impact new approaches for treatment of human disease that arise from academic basic science efforts are often untested and pose unacceptable risks for investment of the tremendous capital required to discover and develop a new drug in an industry setting. This is especially true in discovery of new treatment strategies for the most serious of brain disorders, such as Alzheimer's disease, Parkinson's disease, schizophrenia, autism, and others. By incorporating the highest level of drug discovery into academic research, we are able to advance the most exciting scientific breakthroughs beyond the lab and toward the development of patentable and marketable drugs suited for clinical studies.

keywords:N/A

N/A

Total Funding

147

Number of Employees

$16.5M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vanderbilt Center for Neuroscience Drug Discovery News

2022-04-17 - Prothena and Warren Center for Neuroscience Drug Discovery collaborate on new Alzheimer’s disease therape...

“We are enthusiastic about this collaboration with Vanderbilt and its Warren Center for Neuroscience Drug Discovery,” Prothena Chief Scientific...

2022-03-30 - New screening assay for drugs targeting prostate cancer

... PhD, Director of Medicinal Chemistry at the Warren Center for Neuroscience Drug Discovery at Vanderbilt University, the Journal provides...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M14711%N/A
#2
$16.2M147-25%N/A
#3
$23.4M147N/AN/A
#4
$46.9M147-9%N/A
#5
$29.3M1486%N/A